C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives $9.33 Consensus Target Price from Analysts
C4 Therapeutics, Inc. (NASDAQ:CCCC – Get Free Report) has been given an average recommendation of “Hold” by the eight analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and three have issued a buy recommendation on the company. […]
More Stories
Request Price Hits $0.11 (REQ)
Request (REQ) traded up 5.3% against the US dollar during the 24 hour period ending at 11:00 AM Eastern on...
Wharton Business Group LLC Has $367,000 Stock Holdings in United Parcel Service, Inc. (NYSE:UPS)
Wharton Business Group LLC decreased its position in shares of United Parcel Service, Inc. (NYSE:UPS – Free Report) by 5.3%...
Unum Group (NYSE:UNM) Hits New 12-Month High – Time to Buy?
Unum Group (NYSE:UNM – Get Free Report) shares hit a new 52-week high during mid-day trading on Monday . The...
Walgreens Boots Alliance (NASDAQ:WBA) Sets New 12-Month Low – Time to Sell?
Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Free Report)’s share price reached a new 52-week low during mid-day trading on...
Old Republic International (NYSE:ORI) Sets New 52-Week High – What’s Next?
Old Republic International Co. (NYSE:ORI – Get Free Report)’s share price hit a new 52-week high during mid-day trading on...
ATI Physical Therapy, Inc. (NYSE:ATIP) Short Interest Update
ATI Physical Therapy, Inc. (NYSE:ATIP – Get Free Report) was the target of a significant increase in short interest during...